ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 353

Sensitivity of Unique Multidimensional Health Assessment Questionnaire Items Compared to Items on Both the HAQ and MDHAQ in Patients with RA and SLE

Narender Annapureddy1, David Giangreco1, Isabel Castrejón1, Nisha Shetty2, Theodore Pincus1, Joel Block1 and Meenakshi Jolly1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2St. Anthony's Hospital, St. Louis, MO

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: quality of life and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects: Novel Biomarkers and Other Measurements of Disease Activity

Session Type: Abstract Submissions (ACR)

Background/Purpose: Patients with rheumatic diseases have significantly better clinical status in recent years than in previous decades, including rheumatoid arthritis (RA)1 and systemic lupus erythematosus (SLE).2  Therefore, many items in the health assessment questionnaire (HAQ) which were almost always elevated in 1980 when the HAQ3 was reported may be normal at this time.  In 1999, 16% of patients were reported to have HAQ scores of zero, suggesting “no difficulty” in function, but most nonetheless reported problems with function as well as psychosocial issues reflecting “floor effects.” Therefore, a multidimensional HAQ (MDHAQ) was developed to include 13 queries in the user-friendly HAQ format, 8 simple activities of daily living (ADL) from (and identical to) the HAQ, and 5 not on the HAQ: 2 complex activities – “walk 2 miles or 3 kilometers” and “participate in recreation and sports as you would like”, and 3 “psychological” queries – sleep quality, anxiety and depression.  We analyzed mean scores for each of the 13 MDHAQ items in patients with RA and SLE in routine care in an academic rheumatology setting. 

Methods: An MDHAQ is completed in an academic rheumatology setting by each patient at each visit.  The MDHAQ queries 13 items (Table) in the patient-friendly HAQ format, all scored 0-3, with 4 response options: without any difficulty=0, with some difficulty=1, with much difficulty=2 and unable to do=3. Mean scores were analyzed in 140 female patients, 70 who met criteria for RA and 70 for SLE.  Mean scores for each item was computed and compared using a t-test with a p-value of ≤ 0.05 considered significant on 2-tailed tests.  Exploratory factor analysis (Principal Component analysis with varimax rotation) on the 13 items was performed. 

Results: Mean scores for the 8 items a-h found on the HAQ were <0.70 in patients with RA and <0.50 in patients with SLE (Table), but scores were >0.70 in patients with RA and >0.50 in patients with SLE for all 5 items i-m found only on the MDHAQ. Scores of 0 (floor effects) were seen in >49% of RA and >63% of SLE patients for the HAQ and MDHAQ items vs <47% for RA and <54% of SLE patients for the unique MDHAQ items.  Most items loaded into 3 Components: A: activities of simple living (a-h in SLE and items a-c, e-g in RA), B: complex activities (i and j) and C: psychological (k-m). Differences between RA and SLE patients were significant only for items a, b and j.

Conclusion: Scores of 0 are seen on considerably more HAQ items than MDHAQ items.  The MDHAQ identifies patient problems, which are not captured by the HAQ, similar in RA and SLE. Documentation of improvement is not possible when baseline scores are zero. The MDHAQ might be considered for usual clinical care as well as in clinical trials.

 

References:

1.      Sokka T et al. Clin Exp Rheumatol. 2008 Sep-Oct; 26:S35-61.

2.      Urowitz MB et al. J Rheumatol. 1997; 24(6):1061-1065.

3.       Fries JF et al. Arthritis Rheum. 1980;23(2):137-45.

 


Disclosure:

N. Annapureddy,
None;

D. Giangreco,
None;

I. Castrejón,
None;

N. Shetty,
None;

T. Pincus,
None;

J. Block,
None;

M. Jolly,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sensitivity-of-unique-multidimensional-health-assessment-questionnaire-items-compared-to-items-on-both-the-haq-and-mdhaq-in-patients-with-ra-and-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology